...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study

Could someone explain the significance of this release.  Is this totally new information and what will it mean for the share price?

Share
New Message
Please login to post a reply